A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts

Standard

A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts. / Ingre, Caroline; Landers, John E; Rizik, Naji; Volk, Alexander E; Akimoto, Chizuru; Birve, Anna; Hübers, Annemarie; Keagle, Pamela J; Piotrowska, Katarzyna; Press, Rayomand; Andersen, Peter Munch; Ludolph, Albert C; Weishaupt, Jochen H.

In: NEUROBIOL AGING, Vol. 34, No. 6, 06.2013, p. 1708.e1-6.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Ingre, C, Landers, JE, Rizik, N, Volk, AE, Akimoto, C, Birve, A, Hübers, A, Keagle, PJ, Piotrowska, K, Press, R, Andersen, PM, Ludolph, AC & Weishaupt, JH 2013, 'A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts', NEUROBIOL AGING, vol. 34, no. 6, pp. 1708.e1-6. https://doi.org/10.1016/j.neurobiolaging.2012.10.009

APA

Ingre, C., Landers, J. E., Rizik, N., Volk, A. E., Akimoto, C., Birve, A., Hübers, A., Keagle, P. J., Piotrowska, K., Press, R., Andersen, P. M., Ludolph, A. C., & Weishaupt, J. H. (2013). A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts. NEUROBIOL AGING, 34(6), 1708.e1-6. https://doi.org/10.1016/j.neurobiolaging.2012.10.009

Vancouver

Bibtex

@article{121885f2241246bbb5d338c1b6c81f93,
title = "A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts",
abstract = "Profilin 1 is a central regulator of actin dynamics. Mutations in the gene profilin 1 (PFN1) have very recently been shown to be the cause of a subgroup of amyotrophic lateral sclerosis (ALS). Here, we performed a large screen of US, Nordic, and German familial and sporadic ALS and frontotemporal dementia (FTLD) patients for PFN1 mutations to get further insight into the spectrum and pathogenic relevance of this gene for the complete ALS/FTLD continuum. Four hundred twelve familial and 260 sporadic ALS cases and 16 ALS/FTLD cases from Germany, the Nordic countries, and the United States were screened for PFN1 mutations. Phenotypes of patients carrying PFN1 mutations were studied. In a German ALS family we identified the novel heterozygous PFN1 mutation p.Thr109Met, which was absent in controls. This novel mutation abrogates a phosphorylation site in profilin 1. The recently described p.Gln117Gly sequence variant was found in another familial ALS patient from the United States. The ALS patients with mutations in PFN1 displayed spinal onset motor neuron disease without overt cognitive involvement. PFN1 mutations were absent in patients with motor neuron disease and dementia, and in patients with only FTLD. We provide further evidence that PFN1 mutations can cause ALS as a Mendelian dominant trait. Patients carrying PFN1 mutations reported so far represent the {"}classic{"} ALS end of the ALS-FTLD spectrum. The novel p.Thr109Met mutation provides additional proof-of-principle that mutant proteins involved in the regulation of cytoskeletal dynamics can cause motor neuron degeneration. Moreover, this new mutation suggests that fine-tuning of actin polymerization by phosphorylation of profilin 1 might be necessary for motor neuron survival.",
keywords = "Adult, Aged, Aged, 80 and over, Amyotrophic Lateral Sclerosis, Cohort Studies, Female, Frontotemporal Dementia, Germany, Humans, Male, Mass Screening, Middle Aged, Pedigree, Phosphorylation, Point Mutation, Profilins, Sweden, United States, Young Adult",
author = "Caroline Ingre and Landers, {John E} and Naji Rizik and Volk, {Alexander E} and Chizuru Akimoto and Anna Birve and Annemarie H{\"u}bers and Keagle, {Pamela J} and Katarzyna Piotrowska and Rayomand Press and Andersen, {Peter Munch} and Ludolph, {Albert C} and Weishaupt, {Jochen H}",
note = "Copyright {\textcopyright} 2013 Elsevier Inc. All rights reserved.",
year = "2013",
month = jun,
doi = "10.1016/j.neurobiolaging.2012.10.009",
language = "English",
volume = "34",
pages = "1708.e1--6",
journal = "NEUROBIOL AGING",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "6",

}

RIS

TY - JOUR

T1 - A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts

AU - Ingre, Caroline

AU - Landers, John E

AU - Rizik, Naji

AU - Volk, Alexander E

AU - Akimoto, Chizuru

AU - Birve, Anna

AU - Hübers, Annemarie

AU - Keagle, Pamela J

AU - Piotrowska, Katarzyna

AU - Press, Rayomand

AU - Andersen, Peter Munch

AU - Ludolph, Albert C

AU - Weishaupt, Jochen H

N1 - Copyright © 2013 Elsevier Inc. All rights reserved.

PY - 2013/6

Y1 - 2013/6

N2 - Profilin 1 is a central regulator of actin dynamics. Mutations in the gene profilin 1 (PFN1) have very recently been shown to be the cause of a subgroup of amyotrophic lateral sclerosis (ALS). Here, we performed a large screen of US, Nordic, and German familial and sporadic ALS and frontotemporal dementia (FTLD) patients for PFN1 mutations to get further insight into the spectrum and pathogenic relevance of this gene for the complete ALS/FTLD continuum. Four hundred twelve familial and 260 sporadic ALS cases and 16 ALS/FTLD cases from Germany, the Nordic countries, and the United States were screened for PFN1 mutations. Phenotypes of patients carrying PFN1 mutations were studied. In a German ALS family we identified the novel heterozygous PFN1 mutation p.Thr109Met, which was absent in controls. This novel mutation abrogates a phosphorylation site in profilin 1. The recently described p.Gln117Gly sequence variant was found in another familial ALS patient from the United States. The ALS patients with mutations in PFN1 displayed spinal onset motor neuron disease without overt cognitive involvement. PFN1 mutations were absent in patients with motor neuron disease and dementia, and in patients with only FTLD. We provide further evidence that PFN1 mutations can cause ALS as a Mendelian dominant trait. Patients carrying PFN1 mutations reported so far represent the "classic" ALS end of the ALS-FTLD spectrum. The novel p.Thr109Met mutation provides additional proof-of-principle that mutant proteins involved in the regulation of cytoskeletal dynamics can cause motor neuron degeneration. Moreover, this new mutation suggests that fine-tuning of actin polymerization by phosphorylation of profilin 1 might be necessary for motor neuron survival.

AB - Profilin 1 is a central regulator of actin dynamics. Mutations in the gene profilin 1 (PFN1) have very recently been shown to be the cause of a subgroup of amyotrophic lateral sclerosis (ALS). Here, we performed a large screen of US, Nordic, and German familial and sporadic ALS and frontotemporal dementia (FTLD) patients for PFN1 mutations to get further insight into the spectrum and pathogenic relevance of this gene for the complete ALS/FTLD continuum. Four hundred twelve familial and 260 sporadic ALS cases and 16 ALS/FTLD cases from Germany, the Nordic countries, and the United States were screened for PFN1 mutations. Phenotypes of patients carrying PFN1 mutations were studied. In a German ALS family we identified the novel heterozygous PFN1 mutation p.Thr109Met, which was absent in controls. This novel mutation abrogates a phosphorylation site in profilin 1. The recently described p.Gln117Gly sequence variant was found in another familial ALS patient from the United States. The ALS patients with mutations in PFN1 displayed spinal onset motor neuron disease without overt cognitive involvement. PFN1 mutations were absent in patients with motor neuron disease and dementia, and in patients with only FTLD. We provide further evidence that PFN1 mutations can cause ALS as a Mendelian dominant trait. Patients carrying PFN1 mutations reported so far represent the "classic" ALS end of the ALS-FTLD spectrum. The novel p.Thr109Met mutation provides additional proof-of-principle that mutant proteins involved in the regulation of cytoskeletal dynamics can cause motor neuron degeneration. Moreover, this new mutation suggests that fine-tuning of actin polymerization by phosphorylation of profilin 1 might be necessary for motor neuron survival.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Amyotrophic Lateral Sclerosis

KW - Cohort Studies

KW - Female

KW - Frontotemporal Dementia

KW - Germany

KW - Humans

KW - Male

KW - Mass Screening

KW - Middle Aged

KW - Pedigree

KW - Phosphorylation

KW - Point Mutation

KW - Profilins

KW - Sweden

KW - United States

KW - Young Adult

U2 - 10.1016/j.neurobiolaging.2012.10.009

DO - 10.1016/j.neurobiolaging.2012.10.009

M3 - SCORING: Journal article

C2 - 23141414

VL - 34

SP - 1708.e1-6

JO - NEUROBIOL AGING

JF - NEUROBIOL AGING

SN - 0197-4580

IS - 6

ER -